About NygPharma
NygPharma is a Healthcare company based in Delhi (India) founded in 2017. It manufactures pharmaceutical brands for diabetology, vitamins, and cardiology with patient education programs. It operates on a B2B model. The company has 1 employees. Its Indian entity Nyg Pharmaceuticals Private Limited reported revenue of ₹32.6 Lakh. NygPharma offers products and services including Diabetology Products, Vitamins, and Cardiology Products. Its focus areas include Pharmaceuticals, Nutraceuticals, Vitamins and Supplements and Therapeutics.
Company details
NYG Pharmaceuticals produces pharmaceutical formulations in WHO GMP-approved facilities, focusing on diabetology, vitamins, and cardiology. They emphasize high-quality ingredients for effective treatments and offer patient care initiatives like education programs, diabetes camps, and dietitian services to raise awareness about chronic diseases. Based in New Delhi, India, they collaborate with medical professionals to address issues such as vitamin D deficiency and diabetes complications, aiming to improve public health outcomes.
- Headquarters Delhi, India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Website nygpharma.com
- Social LinkedIn
- Legal Name Nyg Pharmaceuticals Pvt Ltd,
- Date of Incorporation 07 Mar, 2017
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹32.6 Lakh
FY 2026 · +127% YoY
- Net Profit₹2.7 Lakh
FY 2026 · 8% margin
- EBITDA₹3.9 Lakh
FY 2026 · 12% margin
- Employee Count1
Associated legal entities of NygPharma
NygPharma operates through Nyg Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nyg Pharmaceuticals Private Limited CIN U74999DL2017PTC314046 | Active | 07 Mar 2017 | New Delhi, Delhi | ₹0.3 Cr | 3 | View details |
Products & Services of NygPharma
NygPharma offers a comprehensive portfolio of products and services, including Diabetology Products, Vitamins, and Cardiology Products.
Formulations for diabetes management and treatment.
Supplements to address vitamin deficiencies and health needs.
Medications for cardiovascular health and related conditions.
Board of directors of Nyg Pharmaceuticals Private Limited (NygPharma)
Nyg Pharmaceuticals Private Limited is the primary company behind NygPharma. The board of Nyg Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Satpal Singh Gulia, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Satpal Singh Gulia DIN 01967405 | Director | 07 Mar 2017 | 9 yrs 8 mo | Nyg Pharmaceuticals Private Limited |
| Sunil Chhikara DIN 03395175 | Director | 07 Mar 2017 | 9 yrs 8 mo | Nyg Pharmaceuticals Private Limited |
| Anil Kumar DIN 07263924 | Director | 07 Mar 2017 | 9 yrs 8 mo | Nyg Pharmaceuticals Private Limited |
Financials of NygPharma
Figures of Nyg Pharmaceuticals Private Limited, the primary company behind NygPharma, for FY 2026. Revenue was ₹32.6 Lakh (+127% year on year). Net profit was ₹2.7 Lakh (8% margin). EBITDA was ₹3.9 Lakh (12% margin). Revenue has grown at a compounded annual rate of +29% over three years and +1% over five years.
- ₹32.6 LakhRevenue · FY 2026 · +127% YoY
- ₹2.7 LakhNet profit · 8% margin
- ₹3.9 LakhEBITDA · 12% margin
- ₹9.1 LakhPaid-up capital
- +29%Revenue CAGR, 3 years
- +1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nyg Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for NygPharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as NygPharma (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 55.41 M | 362 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | |||
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 56.21 M | 144 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NygPharma
NygPharma was founded in 2017.
NygPharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
NygPharma has 1 employees.
The primary company behind NygPharma, Nyg Pharmaceuticals Private Limited, reported revenue of ₹32.6 Lakh for FY 2026, up 127% year on year.
NYG Pharmaceuticals produces pharmaceutical formulations in WHO GMP-approved facilities, focusing on diabetology, vitamins, and cardiology. They emphasize high-quality ingredients for effective treatments and offer patient care initiatives like education programs, diabetes camps, and dietitian services to raise awareness about chronic diseases. Based in New Delhi, India, they collaborate with medical professionals to address issues such as vitamin D deficiency and diabetes complications, aiming to improve public health outcomes.
NygPharma offers Diabetology Products, Vitamins, and Cardiology Products.
NygPharma operates through Nyg Pharmaceuticals Private Limited.
The legal entities of NygPharma currently have 3 directors, including Satpal Singh Gulia, Sunil Chhikara, Anil Kumar.